Clinical Trial Update: CDDO to Treat Solid Tumors and Lymphomas [Phase 1]

View source ↗

Summary

The National Cancer Institute-sponsored Phase 1 trial evaluated CDDO in patients with solid tumors and lymphoma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• CDDO (CDDO)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Solid Tumors, Lymphoma | Phase 1 | Status: COMPLETED